urothelium carcinoma
Conditions
Interventions
Gold Standard:postoperative histopathological diagnosis and follow-up result
Index test:urine cytology artificial intelligence diagnosis
Sponsors
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Age greater than 18 years old; (2) Able to understand the purpose of this clinical trial and sign an informed consent form; (3) Well-prepared and stained slides, clear microscopic observation and scanning, clear and high-quality images; (4) Patients with symptoms of hematuria (intermittent, painless gross hematuria and microscopic hematuria) or bladder irritation (frequency, urgency, dysuria) who have undergone outpatient or inpatient examination; (5) Patients with a history of urothelial carcinoma, recurrence symptoms, and preoperative examination or postoperative outpatient follow-up; (6) Patients undergoing cystectomy or secondary transurethral resection of bladder cancer before surgery; (7) Patients with or without lower urinary tract symptoms undergoing physical examination screening and further examination.
Exclusion criteria
Exclusion criteria: (1) Participants who request to withdraw from this clinical trial midway; (2) Incomplete clinical criteria diagnostic information or inability to obtain a clear diagnostic result; (3) Urine cytology results showing high-grade urothelial cells or suspected high-grade urothelial cells, lacking postoperative pathological results or postoperative negative pathology; (4) Severe fading of slides affecting diagnostic efficacy; (5) Poor imaging quality of scanned images, out of focus and unclear images.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy;sensitivity;Specificity;Positive predictive value;Negative predictive value; | — |
Countries
China
Contacts
Public ContactLin Tianxin
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Outcome results
None listed